Skip to content

Clinical Study on Kajal

A prospective, open label, one arm clinical study to evaluate the safety and efficacy of Retractable Kohl Kajal in healthy female volunteers

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050735
Enrollment
20
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Retractable Kohl Kajal: Dosage form: Solid, Usage: Apply the Kajal and keep it for minimum 16hrs. Duration: One day Control Intervention1: NIL: NIL

Sponsors

Sunshine Industries
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female subjects between the age group of 18 to 50 years. 2. Subjects who are able to give written informed consent and ready to comply with the protocol. 3. Subjects who are regular users of kajal or eye liner

Exclusion criteria

Exclusion criteria: 1. Subjects who are visually impaired or having underlying conditions that potentially impairs their vision. 2. Subjects with known history of allergies or specific allergic reactions upon using ophthalmic cosmetic products. 3. Subjects with presenting ophthalmic conditions like dry eye, cataract, conjunctivitis etc. 4. Subjects who are regular users of prescription or cosmetic contact lens. 5. Subjects who have dark circles under their eyes. 6. Subjects who are reported pregnant/planning a pregnancy or lactating. 7. Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment. 8. Subjects, who in the opinion of the Investigator or the Expert Dermatologist are not eligible for enrolment in the study.

Design outcomes

Primary

MeasureTime frame
1.Smudge Free Hours: 16hrs 2.Onset of Cooling Time: 0-5 min 3.Lasting of Cooling Effect: 10-15 min 4.Smearing/Fading of IP: 16-18hrs Timepoint: Day 1 to Day 2

Secondary

MeasureTime frame
Subject IP Feedback Questionnaire: Total Score of 10Timepoint: Day 1 to Day 2

Countries

India

Contacts

Public ContactDr Ashok Godavarthi

Radiant Research Services Pvt. Ltd

surya.ashok@gmail.com9880999297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026